Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Medtronic
Baxter
Johnson and Johnson
Merck

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Litigation Details for Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Docket ⤷  Free Forever Trial Date Filed 2019-10-29
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Sherry R. Fallon
Parties MSN LABORATORIES PRIVATE LIMITED; MSN PHARMACEUTICALS INC.
Patents 10,034,873; 10,039,757; 7,579,473; 8,497,284; 8,877,776; 9,000,002; 9,724,342
Attorneys Bryce A. Cooper
Firms Morris, Nichols, Arsht & Tunnell; Stamoulis & Weinblatt LLC
Link to Docket External link to docket
Small Molecule Drugs cited in Exelixis, Inc. v. MSN Laboratories Private Limited
The small molecule drugs covered by the patents cited in this case are ⤷  Free Forever Trial and ⤷  Free Forever Trial .
Biologic Drugs cited in Exelixis, Inc. v. MSN Laboratories Private Limited
The biologic drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-10-29 1 Complaint BACKGROUND 18. U.S. Patent No. 8,877,776 (“the ’776 Patent”), entitled “(L)-malate salt of…Product”) prior to the expiration of U.S. Patent No. 8,877,776. … INFRINGEMENT OF US PATENT NO. 8,877,776 28. Exelixis incorporates each…FOR PATENT INFRINGEMENT 1. This is an action for patent infringement under the patent laws…November 4, 2014. The ’776 Patent will expire on October 8, 2030. The ’776 Patent claims crystalline Form External link to document
2021-09-08 196 Notice of Service Initial Invalidity Contentions for U.S. Patent Nos. 7,579,473 and 8,497,284 [CONFIDENTIAL] filed by MSN… 29 October 2019 1:19-cv-02017 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-09-08 197 Notice of Service Initial Invalidity Contentions for U.S. Patent No. 8,877,776 (with Exhibit A) [HIGHLY CONFIDENTIAL]; … 29 October 2019 1:19-cv-02017 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-09-08 198 Notice of Service Infringement Contentions Concerning U.S. Patent No. 7,579,473 and U.S. Patent No. 8,497,284, and (3) Exelixis …Supplemental Infringement Contentions Concerning U.S. Patent No. 8,877,776 filed by Exelixis, Inc..(Raucci, … 29 October 2019 1:19-cv-02017 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-10-12 205 Notice of Service Munson, Ph.D. Concerning Infringement of U.S. Patent No. 8,877,776 filed by Exelixis, Inc..(Raucci, Anthony… 29 October 2019 1:19-cv-02017 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Merck
Medtronic
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.